The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

 According to The Business Research Company’s report for 2023, the global atopic dermatitis market is projected to increase from $6.48 billion (2022) to $7.51 billion (2023), with a 15.7% CAGR. By 2027, it is anticipated to reach $13.06 billion, growing at a 14.9% CAGR.

What was the major driver in the atopic dermatitis market?
The substantial atopic dermatitis prevalence fuels the market’s growth. Atopic dermatitis, or eczema, leads to skin dryness and itching, increasing the demand for diagnosis and treatment. For example, the National Eczema Association reported that in 2021, about 10% of the US population (31.6 million people) had some form of eczema, including 9.6 million children under 18, with 80% developing dermatitis before age 6. Hence, atopic dermatitis’s rising prevalence propels market expansion.

View More On The Atopic Dermatitis Market Report 2023 – https://www.thebusinessresearchcompany.com/report/atopic-dermatitis-global-market-report

What was the key trend in the atopic dermatitis market?
Product innovations are a prominent trend in the atopic dermatitis market. Leading market players are introducing inventive products to enhance their market presence. For instance, in May 2020, France-based pharmaceutical company Sanofi gained FDA approval for Dupixent, a novel dupilumab drug, for treating moderate-to-severe atopic dermatitis. It’s the first and only biologic drug authorized for children aged 6 to 11 with atopic dermatitis, showing clearer skin in just 16 weeks during the phase 3 trial, surpassing topical corticosteroids alone.

Which was the largest region in the atopic dermatitis market?
North America was the largest region in the atopic dermatitis market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the atopic dermatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Who are the atopic dermatitis market prominent players?
Major players in the atopic dermatitis market are Sanofi S.A., Meda AB, Regeneron Pharmaceuticals Inc., Novartis International AG, Pfizer Inc., AbbVie Inc., Astellas Pharma Inc., Arcutis Biotherapeutics Inc., Asana Biosciences LLC, Dermavant Sciences Inc., Eli Lilly and Company, Galderma S.A., Incyte Corporation, Bayer AG, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, and F. Hoffmann-La Roche AG.

Key atopic dermatitis market segments
The global atopic dermatitis market is segmented –
1) By Drug Class: Corticosteroids, Emollients/Moisturizers, IL-4 and PDE4 Inhibitors, Calcineurin Inhibitors, Antibiotics, Other Drug Classes
2) By Mode of Administration: Topical, Injectable, Oral
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Request A Sample Of The Global Atopic Dermatitis Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8285&type=smp

The Atopic Dermatitis Global Market Report 2023  provides a comprehensive overview on the atopic dermatitis market size, trends and drivers, opportunities, strategies, and companies analysis. Through our reports businesses can effectively analyze data and frame well-informed strategies

View More Related Reports –
Actinic Keratosis Treatment Global Market Report 2023
Pruritus Therapeutic Global Market Report 2023
Dermatitis Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model